(More on Colombia here: /colombia) For more information, contact: (U.S.) Andrew Goldman, KEI: andrew.goldman@keionline.org or +1 (202) 332-2670 (Colombia) Andrea Carolina Reyes Rojas, Misión Salud: subdireccion@mision-salud.org (Colombia) Dr. Francisco Rossi, IFARMA: francisco_rossi@hotmail.com Frequently Asked Questions What is happening in Colombia… Continue Reading
Attached is a letter that KEI, Public Citizen, Oxfam America and Health GAP have sent to Senator Hatch, via the Senate Finance Committee, objecting to the pressure his office has put on Colombia over a compulsory license on patents held by Novartis for the cancer drug Gleevec. This refers to the accounts of pressure from Hatch’s office that are described in two letters from the Colombia Embassy in Washington, dated April 27 and April 28, which were recently leaked. Continue Reading
Before the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) presents a legislative package of healthcare reforms to the Senate floor for an up-or-down vote, 13 consumer, patient and health non-profit groups sent a letter to HELP Chairman and Ranking Member to ensure that the final legislative package includes only those bills that the HELP Committee reviewed in mark-up sessions.
(More on Colombia here: /colombia)
On May 16, 2016, 122 health, trade, and intellectual property experts defended the Colombian government’s right to issue a compulsory license on imatinib, an expensive leukemia drug that is being sold at a high price by the Swiss drug company Novartis, in a letter to Colombian President Juan Manuel Santos.
(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) May 16th, 2016 Sally Hu, Ph.D., M.B.A., Senior Licensing and Patenting Manager, Office of Technology Transfer and Innovation Access, National Institute of Dental and Craniofacial… Continue Reading
SCCR 32 Conclusions proposed by the chair. Late Friday May 13, 2016. Nigeria, Bahamas, Brazil, South Africa and Egypt were exceptionnaly interesting. Here is most of what was said including the reading of the proposed conclusions and the comments from… Continue Reading
KEI: I wanted to just address some of the issues on the cross-border relationship with the exceptions. I know the publisher mentioned mention to three step test. There are three important exceptions that are not related to the three step… Continue Reading
> SOUTH AFRICA: Thank you, Mr. Chairman. At the outset, South Africa supports the statement made by Nigeria on behalf of the Africa Group. 2015 was a milestone in the global calendar. We adopted agenda 2030, which outlined 17 goals… Continue Reading
Day 4. May 12, 2016 After the Chair Summary of the previous discussions on libraries and archives limitations and exceptions we heard the goup statements. In brief, Group B (the rich countries) stated that the discussions should continue to get… Continue Reading
>> EIFL.NET: I will start with retracted and withdrawn works. So libraries and archives have a mandate to pre seven public record for the future. In the analog aenvironment exhaustion to the distribution right provides legal means to insure its… Continue Reading